Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Guru Terug naar discussie overzicht

****MVIS 2007******

13.632 Posts
Pagina: «« 1 ... 552 553 554 555 556 ... 682 »» | Laatste | Omlaag ↓
  1. blup1 31 juli 2007 15:08
    hehe heb je ingsel weer.
    ben idd benieuwd of tr een leuk verkooppraatje komt vandaag.
    ben je weer terug Yankee? was het leuk?
  2. maxl1 31 juli 2007 22:15
    Financial Results
    For the six months ended June 30, 2007, the company reported revenue of $4.9 million compared to $4.4 million for the same period in 2006 and $2.7 million for the three months ended June 30, 2007 compared to $1.9 million for the same period in 2006. As of June 30, 2007, the backlog totaled $7.7 million compared to $1.5 million at June 30, 2006.

    The company reported an operating loss for the six months ended June 30, 2007 of $12.3 million compared to $14.4 million for the same period in 2006 and $6.3 million for the three months ended June 30, 2007 compared to $7.8 million for the same period in 2006.

    The company reported a net loss available to common shareholders of $9.0 million for the six months ended June 30, 2007 compared to $10.9 million for the same period in 2006 and $2.2 million for the three months ended June 30, 2007 compared to $11.2 million for the same period in 2006. The net loss per share was $0.21 for the six months ended June 30, 2007 compared to $0.40 for the same period in 2006 and $0.05 for the three months ended June 30, 2007 compared to $0.38 for the same period in 2006. The net loss available for common shareholders for both the six months ended June 30, 2007 and 2006 includes a gain on the sale of the company's investment in Lumera of $6.0 million and $7.3 million respectively. The three and six month periods ended June 30, 2007 include non cash expenses of $1.9 million and $2.6 million, respectively, compared to non cash gains of $1.2 million and $3.1 million for the same periods in 2006, respectively, associated with the change in value of warrants issued to former holders of the company's notes.

    The company ended the quarter with $17.2 million in cash, cash equivalents and investment securities, including $6.0 million from the conversion of 2.3 million public warrants. Subsequent to the end of the quarter, the Company received an additional $28.1 million from the conversion of an additional 10.6 million warrants.

    "Our strong second quarter and first half business and operational results demonstrate continued rapid advancement of the PicoP roadmap focused on commercializing a variety of high volume products in the consumer and automotive markets. We believe that the most recent development agreement with Motorola provides a significant validation point of our consumer go-to-market strategy and execution," concluded Tokman.


    RS4
  3. [verwijderd] 31 juli 2007 22:30
    Microvision Announces Second Quarter Operating and Financial Results
    Tuesday July 31, 4:05 pm ET
    Company Raises $34.1 Million; Signs Development Agreement With Motorola


    REDMOND, Wash.--(BUSINESS WIRE)--Microvision, Inc. (NASDAQ:MVIS - News), a global leader in light scanning technologies, today reported operating and financial results for the second quarter of 2007.
    "We achieved significant business, operating and financial milestones in the second quarter that could have long-term impact for the Company," stated Alexander Tokman, Microvision President and CEO. "First, our business development efforts during the second quarter resulted in several new customer contracts including the joint development agreement with Motorola and new development contracts for aerospace and eyewear applications. Second, we developed and successfully unveiled at the Society of Information Display (SID) conference a new wide angle design PicoP display that better addresses consumer needs. Third, we made good progress in solidifying several key areas of our supply chain. Finally, we raised $34.1 million from calling our publicly traded warrants."


  4. [verwijderd] 31 juli 2007 22:31
    Second Quarter 2007 Operating Results

    PicoP for Mobile Projection Applications. Announced subsequent to the end of the quarter an agreement with Motorola to develop pico projector display solutions for mobile applications using Microvision's PicoP display engine.
    PicoP for Eyeware Applications. Awarded a $3.2 million contract from the U.S. Air Force to provide a lightweight, see-through, full-color eyewear display prototype.
    PicoP for Aerospace Applications. Signed a new commercial product development agreement with a leading transportation company to develop PicoP based display solution for an aerospace application.
    PicoP Development and Supply Chain Progress.
    -- Unveiled the next generation PicoP display based on a newly
    developed wide-angle MEMS scanner at the May 2007 SID
    conference. The wide-angle PicoP, developed based on direct
    customer feedback, creates a full-color image with
    approximately four times the viewing area of the Company's
    previous display, while still maintaining its small and sleek
    form factor.

    -- Completed and announced the successful integration of a
    green laser from OSRAM Opto Semiconductors into PicoP
    prototype display. Previously, Microvision had announced
    PicoP compatibility with green lasers from Corning and
    Novalux.

    -- Formally introduced Oerlikon Optics as one of the high
    volume manufacturing partners for PicoP after originally
    announcing the joint development effort in December 2006.
    Microvision has been collaborating with this global leader in
    optical component solutions to optimize the design for
    manufacturing of Microvision's opto-mechanical engine
    targeted for high volume consumer and automotive
    applications.

    New Laser Bar Code Scanner. Unveiled ROV(TM), a new laser based bar code scanner incorporating Microvision's core MEMS scanning beam technology. The ROV Scanner was developed for use with mobile applications to provide simple and affordable "point of scan" capability.
    Funding. Exercised the company's right to call its publicly traded warrants -- raising $34.1 million to fund Microvision's continuing operations without an increase to the company's fully diluted common shares outstanding.

13.632 Posts
Pagina: «« 1 ... 552 553 554 555 556 ... 682 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.017
AB InBev 2 5.495
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.626
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.629
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.748
Aedifica 3 914
Aegon 3.258 322.800
AFC Ajax 538 7.088
Affimed NV 2 6.296
ageas 5.844 109.891
Agfa-Gevaert 14 2.050
Ahold 3.538 74.335
Air France - KLM 1.025 35.043
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.790
Allfunds Group 4 1.470
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 243.118
AMG 971 133.308
AMS 3 73
Amsterdam Commodities 305 6.689
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.997
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.773
Arcelor Mittal 2.033 320.699
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.300
Aroundtown SA 1 219
Arrowhead Research 5 9.734
Ascencio 1 27
ASIT biotech 2 697
ASMI 4.108 39.096
ASML 1.766 106.997
ASR Nederland 21 4.483
ATAI Life Sciences 1 7
Atenor Group 1 491
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.666
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392

Macro & Bedrijfsagenda

  1. 21 februari

    1. Duitse verkiezingen (op 23 februari)
    2. Inflatie januari (Jap)
    3. Samengestelde inkoopmanagersindex februari (Jap)
    4. Investeringen december (NL)
    5. Prijzen bestaande koopwoningen januari (NL)
    6. Heijmans Q4-cijfers
    7. Cofinimmo Q4-cijfers
    8. Brunel Q4-cijfers
    9. Detailhandelsverkopen januari (VK)
    10. Samengestelde inkoopmanagersindex februari (Fra)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht